Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage

被引:13
|
作者
Nagamachi, Seiji [1 ]
Ohsawa, Isao [1 ]
Suzuki, Hiyori [1 ]
Sato, Nobuyuki [1 ]
Inoshita, Hiroyuki [1 ]
Hisada, Atsuko [1 ]
Honda, Daisuke [1 ]
Shimamoto, Mamiko [1 ]
Shimizu, Yoshio [1 ]
Horikoshi, Satoshi [1 ]
Tomino, Yasuhiko [1 ]
机构
[1] Juntendo Univ, Fac Med, Dept Internadl Med, Div Nephrol, Tokyo, Japan
关键词
ALTERNATIVE PATHWAY; IGA NEPHROPATHY; ACTIVATION; CELLS; BINDING; EXCRETION; SURFACES; DISEASE; KIDNEY; INJURY;
D O I
10.1186/1471-2369-15-82
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Urinary (U)-complement components have been detected in patients with proteinuric renal diseases, and complement activation via the alternative pathway (AP) is believed to play a role in renal tubular damage. The present study aimed to examine the regulation of complement AP activation in patients with renal tubular damage by focusing on the balance between properdin (P) and factor H (fH). Methods: In the in vivo studies, U concentrations of P, fH and membrane attack complex (MAC) were measured in patients with renal diseases using an enzyme-linked immunosorbent assay (ELISA), and their relationships with the clinical data were evaluated. In the in vitro studies, human proximal tubular epithelial cells (PTECs) were incubated with normal human serum (NHS), P-depleted serum (PDS), purified P and/or fH. Changes in cell morphology and phenotype were assessed by microscopy, real-time polymerase chain reaction (PCR), immunostaining and a cell viability assay. Results: The U-P, fH and MAC concentrations were significantly higher in patients with renal disease than in normal controls and correlated with the U-protein and tubular damage markers. Furthermore, multivariate analysis revealed a relationship between P levels and tubular damage markers. There were no significant changes in morphology and mRNA expression in the AP components (P, fH, fB, C3, C5 and C9) after the addition of up to 25% NHS. Dose-dependent depositions of P or fH were observed after the addition of P or fH on PTECs. Depositions of P were not inhibited by fH in a mixture of a fixed concentration of P and a variable concentration of fH, and vice versa. Preincubation with the fixed concentration of P before the addition of NHS or PDS increased the depositions of P, C3 and MAC compared with incubation with intact NHS or intact PDS only; the depositions of C3 and MAC showed a serum-dependent trend. Preincubation with P before NHS addition significantly suppressed cell viability without causing morphological changes. Conclusions: In the pathogenesis of renal tubular damage, P can directly bind to PTECs and may accelerate AP activation by surpassing fH regulation.
引用
下载
收藏
页数:11
相关论文
共 50 条
  • [41] Serum-sensitive Borrelia garinii producing CRASP-1 orthologs of serum-resistant spirochetes evades complement-mediated lysis by interaction with human complement factor H and factor H-like protein 1
    Hammerschmidt, C.
    Siegel, C.
    Skerka, C.
    Wallich, R.
    Zipfel, P. F.
    Kraiczy, P.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 299 : 68 - 68
  • [42] BbCRASP-2, a novel outer membrane protein of Borrelia burgdorferi that imparts resistance to complement-mediated lysis by binding of host complement regulators factor H and FHL-1
    Zipfel, Peter F.
    Hartman, Kristina
    Corvey, Carsten
    Skerka, Christine
    Kirschfink, Michael
    Karas, Michael
    Brade, Volker
    Miller, Jennifer C.
    Stevenson, Brian
    Wallich, Reinhard
    Kraiczy, Peter
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 265 - 265
  • [43] TEST FOR ABILITY OF DECAY-ACCELERATING FACTOR (DAF, CD55) AND CD59 TO ALLEVIATE COMPLEMENT-MEDIATED DAMAGE OF XENO-ERYTHROCYTES
    MIYAGAWA, S
    SHIRAKURA, R
    MATSUMIYA, G
    NAKATA, S
    MATSUDA, H
    HATANAKA, M
    MATSUMOTO, M
    KITAMURA, H
    SEYA, T
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1993, 38 (01) : 37 - 44
  • [44] The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment
    Risitano, Antonio M.
    Notaro, Rosario
    Pascariello, Caterina
    Sica, Michela
    del Vecchio, Luigi
    Horvath, Christopher J.
    Fridkis-Hareli, Masha
    Selleri, Carmine
    Lindorfer, Margaret A.
    Taylor, Ronald P.
    Luzzatto, Lucio
    Holers, V. Michael
    BLOOD, 2012, 119 (26) : 6307 - 6316
  • [45] MASP3 deficiency ameliorates but does not completely prevent alternative pathway complement-mediated tissue injury in a factor H mutant mouse model
    Kim, Hangsoo
    Gullipalli, Damodar
    Miwa, Takashi
    Sato, Sayaka
    Golla, Madhu
    Palmer, Matthew
    Song, Wen-Chao
    IMMUNOBIOLOGY, 2023, 228 (05) : 101 - 101
  • [46] Painting factor H onto mesenchymal stem cells protects the cells from complement- and neutrophil-mediated damage
    Li, Yan
    Qiu, Wen
    Zhang, Lingjun
    Fung, John
    Lin, Feng
    BIOMATERIALS, 2016, 102 : 209 - 219
  • [47] Gain-of-function factor H-related 5 protein impairs glomerular complement regulation resulting in kidney damage
    Malik, Talat H.
    Gitterman, Daniel P.
    Lavin, Deborah P.
    Lomax-Browne, Hannah J.
    Hiemeyer, E. Christina
    Moran, Linda B.
    Boroviak, Katharina
    Cook, H. Terence
    Gilmore, Alyssa C.
    Mandwie, Mawj
    Ahmad, Amina
    Alexander, Ian E.
    Logan, Grant J.
    Marchbank, Kevin J.
    Bradley, Allan
    Pickering, Matthew C.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (13)
  • [48] Painting factor H onto mesenchymal stem cells protects the cells from complement- and neutrophil-mediated damage
    Li, Yan
    Qiu, Wen
    Zhang, Lingjun
    Fung, John
    Lin, Feng
    IMMUNOBIOLOGY, 2016, 221 (10) : 1133 - 1133
  • [49] Case Report: Severe Complement-Mediated Thrombotic Microangiopathy in IgG4-Related Disease Secondary to Anti-Factor H IgG4 Autoantibodies
    Breville, Gautier
    Zamberg, Ido
    Sadallah, Salima
    Stephan, Caroline
    Ponte, Belen
    Seebach, Jorg D.
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [50] PHOSPHOLIPID-ANCHORED AND TRANSMEMBRANE VERSIONS OF EITHER DECAY-ACCELERATING FACTOR OR MEMBRANE COFACTOR PROTEIN SHOW EQUAL EFFICIENCY IN PROTECTION FROM COMPLEMENT-MEDIATED CELL-DAMAGE
    LUBLIN, DM
    COYNE, KE
    JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (01): : 35 - 44